Doxorubicin hydrochloride is prescribed for the treatment of patients with ovarian cancer whose disease has progressed or recurred after platinum-based chemotherapy. Doxorubicin hydrochloride under the trade name Doxil was approved in 1995 in the USA by FDA, for the treatment of AIDS-related Kaposi sarcoma in patients with disease that has progressed on prior combination therapy or in patients who are intolerant to such therapy. The medication is presently approved in many countries and is available in both generic and trade name versions. One of the more popular branded versions of Doxorubicin hydrochloride is manufactured and supplied by the Chinese pharmaceutical company, Beijing THTD Pharmaceutical Technology Co., Ltd. Other manufacturing companies and distributors from Argentina, Guatemala, India, Paraguay, Indonesia, the UK, Germany, South Korea, and Switzerland, have also successfully adapted to the demands of the global marketplace and produced a variant of the drug with Doxorubicin hydrochloride as an active ingredient. Warnings: Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking DOXORUBICIN HYDROCHLORIDE: You should not use This medical drug if you are allergic to it This drug may also be used for purposes that may not have been listed in this medication guide. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified rosiglitazone manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

The usage of this pharmaceutical substance: Read the Guide and, if available, the Patient Information Leaflet that will be provided by your pharmacist before you start taking DOXORUBICIN HYDROCHLORIDE. If you have any questions related to this medical remedy, ask your pharmacist or doctor. The drug is used to treat AIDS-related Kaposi sarcoma in patients after failure of prior systemic chemotherapy or intolerance to such therapy. In combination with bortezomib, the drug is indicated for the treatment of patients with multiple myeloma who have not previously received bortezomib and have received at least one prior therapy. The medication is available for sale in the form of powder for solution for injection Single-dose Vial, solution for injection at concentration 2mg/ml, ampoules with 25 ml of substance per unit, solution for injection/infusion at concentrations 20mg and 50mg, and vials with 5 ml of the substance per unit, from manufacturers in various countries including Y. The drug is provided by a wide range of Doxorubicin hydrochloride suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Doxorubicin hydrochloride manufacturers and distributors are based in China, India, and Japan.

The wholesale acquisition cost of medication in the U.S. for Doxorubicin hydrochloride intravenous solution (2 mg/mL) is around 17 USD for a supply of 5 milliliters of the substance. The retail price in the EU of this drug depending on the pack size ranges between 30 EUR and 40 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier.

If you are looking to find manufacturers and suppliers of DOXORUBICIN HYDROCHLORIDE, locate them quickly using Pipelinepharma's online marketplace. With this convenient B2B platform, you can order types of medications and quantities you require from companies that have passed our stringent vetting and quality control procedures. Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of DOXORUBICIN HYDROCHLORIDE offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and these substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of DOXORUBICIN HYDROCHLORIDE. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where DOXORUBICIN HYDROCHLORIDE is already registered in. Manufacturers also have special, and delivery terms.

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen DOXORUBICIN HYDROCHLORIDE manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.